sandeep mittal
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Mysore
Mysore, India
Review Editor
Cancer Molecular Targets and Therapeutics
Massachusetts General Hospital Cancer Center
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Autonomous University of Mexico
MĂ©xico City, Mexico
Review Editor
Cancer Molecular Targets and Therapeutics
Université Clermont Auvergne
Clermont-Ferrand, France
Review Editor
Cancer Molecular Targets and Therapeutics
Washington University in St. Louis
St. Louis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Feinberg School of Medicine, Northwestern University
Chicago, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Minnesota Twin Cities
St. Paul, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Wayne State University
Detroit, United States
Review Editor
Cancer Molecular Targets and Therapeutics
WUGEN
Saint Louis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Saarland University Hospital
Homburg, Germany
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Sapienza University of Rome
Rome, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of Rome Tor Vergata
Roma, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics